ESCM
AXSM icon

Echo Street Capital Management’s Axsome Therapeutics AXSM Stock Holding History

Echo Street Capital Management’s Portfolio AXSM Stock Details AXSM Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2021
Q2 		– Sell
-7,299
Closed -$413K – 592
2021
Q1 		$413K Buy
+7,299
New +$513K ﹤0.01% 350

Other funds holding AXSM

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
IAM
Iridian Asset Management Westport, Connecticut $291M AUM 49.45% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
RCM
RA Capital Management Boston, Massachusetts $11.5B AUM 168.77% 1-Year Est. Return
RI
RTW Investments New York $11.7B AUM 174.13% 1-Year Est. Return
ACM
Alethea Capital Management Mercer Island, Washington $241M AUM 112.74% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $999B AUM 46.22% 1-Year Est. Return
Nuveen
Nuveen Charlotte, North Carolina $419B AUM 43.02% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Citadel Advisors
Citadel Advisors Miami, Florida $875B AUM 40.89% 1-Year Est. Return

Echo Street Capital Management's AXSM Position: Q2 2021 in Review

Echo Street Capital Management sold out of Axsome Therapeutics (AXSM) in Q2 2021, closing a stake of 7,299 shares — an estimated $413K sold.

Echo Street Capital Management first reported a position in AXSM in Q1 2021 and held it in 1 quarter. The position peaked at $413K in Q1 2021. 176 funds tracked by Wall St. Rank hold AXSM as of Q2 2021.

  • Echo Street Capital Management reported no remaining Axsome Therapeutics position as of Q2 2021 after selling out during the quarter.
  • Echo Street Capital Management sold 7,299 Axsome Therapeutics shares in Q2 2021, an estimated $413K.
  • Echo Street Capital Management first reported a position in Axsome Therapeutics in Q1 2021 and held it in 1 quarter.
  • Echo Street Capital Management's Axsome Therapeutics position peaked at $413K in Q1 2021.
  • 176 funds tracked by Wall St. Rank held Axsome Therapeutics as of Q2 2021.

Based on Echo Street Capital Management's 13F filing for Q2 2021, filed 16 Aug 2021.